1. American Journal of Obstetrics and Gynecology: Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. Available from: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W9P-45SR5XHFH&_user=14781.... Last Accessed March 2010.
2. Jolly et al. Risk factors for macrosomia and its clinical consequences: A Study of 350,311 Pregnancies. Eur J Obst Gynecol 2003; 111 (1): 9–14.
3. Casson IF et al. Outcomes of Pregnancy in insulin dependent women: Results of a five year cohort study. Br Med J 1997; 315: 275–8.
4. Diabetes Care: Microalbuminuria, preeclampsia and preterm delivery in pregnant women with type 1 diabetes – results from a nation-wide Danish study. Available from: http://care.diabetesjournals.org/content/early/2009/10/19/dc09-1219. Last Accessed March 2010.
5. Temple RC et al. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type 1 diabetes. Br J Obst Gynecol 2006; 113 (11).
6. Hawthorne G et al. Prospective population based survey of outcome of pregnancy in diabetic women: Results of the northern diabetic pregnancy audit 1994. Br Med J 1997; 315: 279–81.
7. Temple R et al. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: Population based study. Br Med J 2002; 325: 1275–6.
8. Cornblath M et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds paediatrics 2000; 105 (5): 1141–5.
9. American Diabetes Association: Preconception care of women with diabetes. Available at: http://care.diabetesjournals.org/content/26/suppl_1/s91.full. Last accessed February 2010.
10. International Diabetes Federation: Diabetes and pregnancy. Available at: http://www.idf.org/webdata/docs/Pregnancy_EN_RTP. pdf. Last accessed February 2010.
11. National Collaborating Center for Women’s and Children’s Health NICE. Diabetes in Pregnancy. Clinical Guidelines. Available from: http://guidance.nice.org.uk/CG63. Last accessed March 2010.
12. Moses RG, Lucas EM, Knights S. Gestational diabetes mellitus: At what time should the postprandial glucose level be monitored? Australia and New Zealand J Obst Gynecol 1999; 39 (4): 57–60.
13. Sivan E et al. One or two hours postprandial glucose measurements: Are they the same? Am J Obst Gynecol 2001; 185 (3): 604–7.
14. De Veciana M et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Eng J Med 1995; 333 (19): 1237–41.
15. Mathiesen E et al. Maternal glycaemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007; 30 (4): 771–6.
16. Hod M et al. Fetal and Perinatal Outcomes in Type 1 Diabetes Pregnancy: A Randomized Study Comparing Insulin Aspart with Human Insulin in 322 Subjects. Am J Obst Gynecol 2008; 198 (2): 186.
17. Lloyd A et al. Cost-Effectiveness of Insulin Aspart Compared to Human Insulin in Pregnant Women with Type 1 Diabetes in the UK. Curr Med Res Opin 2009; 25 (3): 599–605.
18. Petitt DJ et al. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 2003; 26 (1): 183–6.
19. Mukhopadhyay A et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: A systematic review and meta-analysis of randomized, Controlled Trials. Am J Obst Gynecol 2007; 197 (5): 447–56.
Авторы
И.Ю.Демидова1, Н.Ю.Арбатская2
1 ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздравсоцразвития РФ;
2 КДЦ ГКБ №1 им. Н.И.Пирогова